CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Experimental AAC +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04247828
NCT04247828N/ACompleted
CompareCT.gov

Adaptive and Individualized AAC

Altec Inc.·interventional·Posted Jan 30, 2020·Updated Apr 6, 2022

In Brief

A clinical study evaluating Experimental AAC and Generic AAC for Communication Disorders. Completed, enrolled 30 participants across 2 sites.

Detailed Summary

This project will test the feasibility of developing a smart augmentative or alternative communication (AAC) system that is effective in delivering communication capabilities that automatically adapt to the users' physical abilities.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCommunication Disorders
CountriesUnited States
CollaboratorsMadonna Rehabilitation Hospital

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 30, 2020
Enrollment StartJan 6, 2020
Primary CompletionAug 31, 2021
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 6.4 years ago

Interventions

Experimental AACdevice

Participant receives an AAC system comprising a single hybrid wearable sensor for head-mediated cursor control that is integrated with an adaptive and individualized keyboard to test communication performance.

Generic AACdevice

Participant receives an AAC system comprising a single hybrid wearable sensor for head-mediated cursor control that is integrated with a generic QWERTY keyboard to test communication performance.